These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7333866)

  • 1. Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function.
    Seger RA; Baumgartner S; Tiefenauer LX; Gmünder FK
    Helv Paediatr Acta; 1981; 36(6):579-88. PubMed ID: 7333866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of antibiotics in chronic granulomatous disease leukocytes.
    Jacobs RF; Wilson CB
    Pediatr Res; 1983 Nov; 17(11):916-9. PubMed ID: 6646904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial prophylaxis in chronic granulomatous disease. A case report.
    Mendelsohn HB; Berant M; Merzbach D
    Isr J Med Sci; 1983 Nov; 19(11):1004-5. PubMed ID: 6607239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim.
    Gmünder FK; Seger RA
    Pediatr Res; 1981 Dec; 15(12):1533-7. PubMed ID: 7322675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).
    Kobayashi Y; Amano D; Ueda K; Kagosaki Y; Usui T
    Eur J Pediatr; 1978 Apr; 127(4):247-54. PubMed ID: 668710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole.
    Tsuji S; Taniuchi S; Hasui M; Yamamoto A; Kobayashi Y
    Nitric Oxide; 2002 Dec; 7(4):283-8. PubMed ID: 12446177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease.
    Zimmerli W; Lew PD; Suter S; Wyss M; Waldvogel FA
    Helv Paediatr Acta; 1983 Mar; 38(1):51-61. PubMed ID: 6862995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of trimethoprim-sulfamethoxazole in gonococcal infections.
    Austin TW; Holmes KK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):37-9. PubMed ID: 805648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
    Rawal BD; Cottis L
    Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine in chronic granulomatous disease.
    Granzotto M; Leone V; Lepore L; Zerial M; Tommasini A; Ciambra R; Gombac F; Ventura A
    Pediatr Hematol Oncol; 2005 Mar; 22(2):147-51. PubMed ID: 15805000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progressive-septic granulomatosis: improved prognosis with early diagnosis and targeted therapy. Report of 5 cases].
    Kremens B; Seger RA; von Voss H; Wahn V
    Monatsschr Kinderheilkd; 1985 May; 133(5):284-90. PubMed ID: 3925328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole in chronic bronchitis.
    Jordan GW; Krajden SF; Hoeprich PD; Wong GA; Peirce TH; Rausch DC
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):91-5. PubMed ID: 1137833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and current management of chronic granulomatous disease.
    Forrest CB; Forehand JR; Axtell RA; Roberts RL; Johnston RB
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):253-66. PubMed ID: 2839458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.
    McDonald C; Faridah
    J Parenter Sci Technol; 1991; 45(3):147-51. PubMed ID: 1886043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes.
    Höger PH; Seger RA; Schaad UB; Hitzig WH
    Pediatr Res; 1985 Jan; 19(1):38-44. PubMed ID: 3969311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of defective bactericidal capacity of polymorphonuclear leukocytes by isoniazide in a case of chronic granulomatous disease.
    Megyeri P; Endreffy E
    Acta Paediatr Scand; 1986 Jul; 75(4):668-9. PubMed ID: 3489348
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease.
    Weening RS; Kabel P; Pijman P; Roos D
    J Pediatr; 1983 Jul; 103(1):127-30. PubMed ID: 6408232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease.
    Fanconi S; Seger R; Gmür J; Willi U; Schaer G; Spiess H; Otto R; Hitzig WH
    Helv Paediatr Acta; 1985 Sep; 40(4):277-84. PubMed ID: 3878346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.